Bifarcept

• Description :

  Bifarcept is an interferon receptor type I (IFN-RI) fusion protein. Bifarcept can bind interferon receptors and prolong its serum half-life[1].

• CAS Number :

  [163796-60-9]

• UNSPSC :

  12352203

• Target :

  IFNAR

• Type :

  Inhibitory Antibodies

• Related Pathways :

  Immunology/Inflammation

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/bifarcept.html

• Solubility :

  10 mM in DMSO

• Smiles :

  [Bifarcept]

• References & Citations :

  [1]Bilsborough J, et, al. From model to mechanism: lessons of mice and men in the discovery of protein biologicals for the treatment of inflammatory bowel disease. Expert Opin Drug Discov. 2006 Jun;1 (1) :69-83.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  No Development Reported